José Thomas

7.0k citations

77 papers · 4.3k indexed · h-index 38

Impact in

Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment

Papers in ⓘ

Pathology and Forensic Medicine 59
- Lymphoma Diagnosis and Treatment 57
- Genetic factors in colorectal cancer 3
Genetics 25
- Chronic Lymphocytic Leukemia Research 25
- Genomic variations and chromosomal abnormalities 3

Co-authors: Patrice Carde (25 shared papers)Peter Vandenberghe (9 shared papers)Sigrid Stroobants (8 shared papers)Karoline Spaepen (6 shared papers)Gregor Verhoef (12 shared papers)Patrick Dupont (5 shared papers)M. Henry‐Amar (18 shared papers)Iwona Włodarska (15 shared papers)
Journals: Journal of Clinical Oncology (12 papers)Blood (11 papers)Annals of Oncology (7 papers)European Journal of Cancer (5 papers)Cancer (3 papers)
Partner nations: Belgium Netherlands France

In The Last Decade

José Thomas

77 papers receiving 4.2k citations

Peers

Countries citing papers authored by José Thomas

Since Specialization

Citations

This map shows the geographic impact of José Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Thomas more than expected).

Fields of papers citing papers by José Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Thomas. The network helps show where José Thomas may publish in the future.

Co-authors

The 25 scholars most cited alongside José Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with José Thomas Line = papers co-authored together José Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prognostic Value of Positron Emission Tomography (PET) With Fluorine-18 Fluorodeoxyglucose ([¹⁸F]FDG) After First-Line Chemotherapy in Non-Hodgkin’s Lymphoma: Is [¹⁸F]FDG-PET a Valid Alternative to Conventional Diagnostic Methods? Journal of Clinical Oncology ·Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, Steven Van Steenweghen, José Thomas, Peter Vandenberghe, Lucien Vanuytsel, Guy Bormans, Jan Balzarini, Christine De Wolf‐Peeters, Luc Mortelmans, Gregor Verhoef	2001	344
2	Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma Annals of Oncology ·Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, Peter Vandenberghe, José Thomas, Tjibbe de Groot, Jan Balzarini, C. De Wolf‐Peeters, L. Mortelmans, G. Verhoef	2002	317
3	High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 Journal of Clinical Oncology ·Philip Poortmans, Hanneke C. Kluin‐Nelemans, Hanny Haaxma-Reiche, Mars van’t Veer, Mads Hansen, Pierre Soubeyran, Martin Taphoorn, José Thomas, Martin J. van den Bent, M. Fickers, Gustaaf van Imhoff, Cynthia Rozewicz, Ivana Teodorović, M. van Glabbeke	2003	233
4	Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features [see comments] Blood ·Judith Dierlamm, Stefania Pittaluga, Iwona Włodarska, M.S Stul, José Thomas, M. Boogaerts, Lennard Michaux, Ann Driessen, Cristina Mecucci, JJ Cassiman	1996	203
5	Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987 Blood ·M Tubiana, M. Henry‐Amar, Patrice Carde, J M Burgers, M. Hayat, Emmanuel van der Schueren, E.M. Noordijk, A Tanguy, J.H. Meerwaldt, José Thomas	1989	191
6	CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. Journal of Clinical Oncology ·Umberto Tirelli, D. Errante, M. van Glabbeke, Ivana Teodorović, Hanneke C. Kluin‐Nelemans, José Thomas, Dominique Bron, Giovanni Rosti, R. Somers, Vittorina Zagonel, E.M. Noordijk	1998	175
7	Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation Blood ·Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, Peter Vandenberghe, Johan Maertens, Guy Bormans, José Thomas, Jan Balzarini, Christine De Wolf‐Peeters, Luc Mortelmans, Gregor Verhoef	2003	171
8	Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials Journal of Clinical Oncology ·Evert M. Noordijk, Patrice Carde, N. Dupouy, Anton Hagenbeek, Augustinus D. G. Krol, Hanneke C. Kluin‐Nelemans, Umberto Tirelli, M. Monconduit, José Thomas, Houchingue Eghbali, Berthe M.P. Aleman, Jacques Bosq, Marjeta Vovk, Tom Verschueren, Anne-Marie Pény, T. Girinsky, John Raemaekers, M. Henry‐Amar	2006	149
9	Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. Journal of Clinical Oncology ·Patrice Carde, Anton Hagenbeek, M. Hayat, M. Monconduit, José Thomas, M J Burgers, Evert M. Noordijk, A Tanguy, J.H. Meerwaldt, R. Le Fur	1993	139
10	Can positron emission tomography with [¹⁸F]‐fluorodeoxyglucose after first‐line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity? British Journal of Haematology ·Karoline Spaepen, Sigrid Stroobants, Patrick Dupont, José Thomas, Peter Vandenberghe, Jan Balzarini, Christine De Wolf‐Peeters, Luc Mortelmans, Gregor Verhoef	2001	121
11	Forkhead Box Protein P1 Expression in Mucosa-Associated Lymphoid Tissue Lymphomas Predicts Poor Prognosis and Transformation to Diffuse Large B-Cell Lymphoma Journal of Clinical Oncology ·Xavier Sagaert, Pascale De Paepe, Louis Libbrecht, Vera Vanhentenrijk, Gregor Verhoef, José Thomas, Iwona Włodarska, Christiane De Wolf‐Peeters	2006	113
12	Standard Chemotherapy With or Without High-Dose Chemotherapy for Aggressive Non-Hodgkin's Lymphoma: Randomized Phase III EORTC Study JNCI Journal of the National Cancer Institute ·Hanneke C. Kluin‐Nelemans, Vittorina Zagonel, A. Anastasopoulou, Dominique Bron, K. J. Roozendaal, E.M. Noordijk, H. Musson, Ivana Teodorović, Brigitte Maes, Antonino Carbone, Patrice Carde, José Thomas	2001	106
13	Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization Leukemia ·Judith Dierlamm, Carla Rosenberg, Michel Stul, Stefania Pittaluga, Iwona Włodarska, Lucienne Michaux, M.R.M. Dehaen, G. Verhoef, José Thomas, Wim De Kelver, Tom C. Bakker Schut, JJ Cassiman, Anton K. Raap, Chris De Wolf‐Peeters, Herman Van den Berghe, A Hagemeijer	1997	104
14	Translocation (11;14): A cytogenetic anomaly associated with B‐cell lymphomas of non‐follicle centre cell lineage The Journal of Pathology ·Elisabeth Vandenberghe, Chris De Wolf‐Peeters, Joost van den Oord, Ivonna Wlodarska, Jan Delabie, Michel Stul, José Thomas, Jean‐Louis Michaux, Cristina Mecucci, Jean‐Jacques Cassiman, Herman Van den Berghe	1991	98
15	Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. Journal of Clinical Oncology ·Umberto Tirelli, Vittorina Zagonel, Diego Serraino, José Thomas, B Hœrni, A Tangury, U Rühl, P. Bey, N. Tubiana-Mathieu, W.P.M. Breed	1988	92
16	Mantle cell lymphoma: a clinicopathological study of 55 cases Histopathology ·Stefania Pittaluga, Iwona Włodarska, Michel Stul, José Thomas, G. Verhoef, J.J. Cassiman, Herman Van den Berghe, Chris De Wolf‐Peeters	1995	85
17	Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols International Journal of Radiation OncologyBiologyPhysics ·M. Henry‐Amar, M. Hayat, J.H. Meerwaldt, Melanie C. J. Burgers, Patrice Carde, R. Somers, E.M. Noordijk, M. Monconduit, José Thomas, Jean‐Marc Cosset, Emmanuel van der Schueren, R Regnier, Dominique Bron, J. Lutsman-Marechal, A Tanguy, Ben de Pauw, M Tubiana	1990	80
18	First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL) Journal of Clinical Oncology ·Evert M. Noordijk, José Thomas, C. Fermé, Manik Veer, Pauline Brice, Marine Diviné, F. Morschhauser, Patrice Carde, Houchingue Eghbali, M. Henry‐Amar	2005	76
19	Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation Blood ·Stefania Pittaluga, Luc Bijnens, Ivana Teodorović, Anton Hagenbeek, J.H. Meerwaldt, R. Somers, José Thomas, E.M. Noordijk, Chris De Wolf‐Peeters	1996	76
20	Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas Blood ·Iwona Włodarska, Daan Dierickx, Vera Vanhentenrijk, Katrien Van Roosbroeck, H Pospíšilová, Francesca Minnei, Gregor Verhoef, José Thomas, Peter Vandenberghe, Chris De Wolf‐Peeters	2008	76

About José Thomas

José Thomas is a scholar working on Pathology and Forensic Medicine, Genetics, Neurology, Pulmonary and Respiratory Medicine and Oncology, having authored 77 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (57 papers), Chronic Lymphocytic Leukemia Research (25 papers), Lung Cancer Treatments and Mutations (20 papers), CNS Lymphoma Diagnosis and Treatment (14 papers), Viral-associated cancers and disorders (13 papers), Medical Imaging Techniques and Applications (7 papers), Genetic factors in colorectal cancer (3 papers) and Genomic variations and chromosomal abnormalities (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.3k citations), Genetics (1.1k citations), Neurology (1.2k citations), Oncology (1.5k citations) and Pulmonary and Respiratory Medicine (1.2k citations). José Thomas has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Patrice Carde, Peter Vandenberghe, Sigrid Stroobants, Karoline Spaepen, Gregor Verhoef, Patrick Dupont, M. Henry‐Amar, Iwona Włodarska, Hanneke C. Kluin‐Nelemans and Jan Balzarini. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, European Journal of Cancer and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact